Pharma Pulse: Industry Backlash, GSK’s $2.2B Immunology Bet, and the Future of Wearables

Jan 21, 10:30 AM
Headliner
Share
Subscribe
In today’s Pharma Pulse, over 200 health groups denounce childhood vaccine schedule cuts, GSK acquires RAPT Therapeutics, and BD partners with ten23 health to scale large-volume injectors.
Share
Subscribe
Next
Pharma Pulse: Federal Funding Averts Shutdown and Pfizer’s Adjuvant Play
Top episodes
Overcoming Supply Chain Challenges
by Pharma Pulse
Incorporating AI into Commercialization Plans
by Pharma Pulse
The Capabilities of a 3PL Provider
by Pharma Pulse